Jason Aryeh, Director at Orchestra BioMed Holdings, Inc. (OBIO), bought 665 shares at $3.75 ($2K) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Open-market purchase of $2k OBIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |
| LGND | BUY | 2019-09-04 | $131K | — | Filing → |